EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathotype-specific antimicrobial resistance in diarrheagenic Escherichia coli: gene variants, resistance mechanisms, and evolution of treatment strategies

Dhamini Kamal Raj, Sai Kiruthiga Saravanan, Anumitha Viswanathan, Santhosh Mudipalli Elavarasu, Sidharth Kumar Nanda Kumar, K S Sridharan, Amudha Govindarajan, Sasikumar Krishnan, Magesh Ramasamy

Frontiers in Microbiology · 27.03.2026 · 17

DOI: 10.3389/fmicb.2026.1770628 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 27.03.2026. Verfasst von Dhamini Kamal Raj und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Biomedical Sciences and Technology, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai,…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diarrheagenic Escherichia coli (DEC) is still a prominent cause of diarrheal disease and mortality in children under five, and it continues to be a significant worldwide health concern. This review summarises and analyses recent findings (2015–2025) on the classification, geographic distribution, antimicrobial resistance (AMR) patterns, and emerging treatment options for six principal DEC pathotypes: enterotoxigenic (ETEC), enteropathogenic (EPEC), enteroaggregative (EAEC), Shiga toxin–producing (STEC/EHEC), enteroinvasive (EIEC), and adherent-invasive (AIEC) strains. Across diverse regions, diarrheagenic E. coli remains widespread in low- and middle-income populations. However, the epidemiological landscape is changing, as EAEC increasingly replaces traditional pathotypes in parts of Africa and Asia. Resistance levels to ampicillin and trimethoprim–sulfamethoxazole frequently surpass 50%, and rising resistance to fluoroquinolones, azithromycin, and third-generation cephalosporins is increasingly documented. The expansion of multidrug resistance is driven by various mechanisms, including the production of extended-spectrum β -lactamase (ESBL), the transfer of plasmid-borne resistance genes, the activation of efflux pumps, and the formation of biofilms. Novel interventions, including bacteriophage therapy, ETEC-focused vaccine candidates, anti-virulence agents, and approaches to modulate gut microbiota, are progressing from laboratory research to clinical evaluation. Addressing the AMR threat in DEC will need integrated One Health surveillance strategies and tailored antimicrobial stewardship measures. The current evidence highlights an urgent need for coordinated international action to reduce the clinical and public health burden associated with DEC.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistancepathotypesphage therapypublic healthvaccine development

Autor:innen und Institutionen

  • Department of Biotechnology, Faculty of Biomedical Sciences and Technology, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai, India.
  • Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India.
  • Central Laboratory Services, Sri Ramachandra Medical Center, Porur, Chennai, India.
  • Department of Pharmacology, Government Medical College, Tiruvallur, India.
  • Sensor and Biomedical Technology, School of Electronics Engineering, Vellore Institute of Technology, Vellore, India.

Zitieren

APA

Kamal Raj, D., Saravanan, S. K., Viswanathan, A., Elavarasu, S. M., Nanda Kumar, S. K., Sridharan, K. S., Govindarajan, A., Krishnan, S., & Ramasamy, M. (2026). Pathotype-specific antimicrobial resistance in diarrheagenic Escherichia coli: gene variants, resistance mechanisms, and evolution of treatment strategies. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1770628

Vancouver

Kamal Raj D, Saravanan SK, Viswanathan A, Elavarasu SM, Nanda Kumar SK, Sridharan KS, et al. Pathotype-specific antimicrobial resistance in diarrheagenic Escherichia coli: gene variants, resistance mechanisms, and evolution of treatment strategies. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1770628

BibTeX
@article{KamalRaj2026,
  author = {Kamal Raj, Dhamini and Saravanan, Sai Kiruthiga and Viswanathan, Anumitha and Elavarasu, Santhosh Mudipalli and Nanda Kumar, Sidharth Kumar and Sridharan, K S and Govindarajan, Amudha and Krishnan, Sasikumar and Ramasamy, Magesh},
  title = {Pathotype-specific antimicrobial resistance in diarrheagenic Escherichia coli: gene variants, resistance mechanisms, and evolution of treatment strategies},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1770628}
}
Kostenlos starten →